Kuhn Deborah, Lam Wai Har, Kazi Aslamuzzaman, Daniel Kenyon G, Song Shuojing, Chow Larry M C, Chan Tak Hang, Dou Q Ping
The Prevention Program, Barbara Ann Karmanos Cancer Institute and Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan 48201, USA.
Front Biosci. 2005 May 1;10:1010-23. doi: 10.2741/1595.
It has been suggested that proteasome activity is essential for tumor cell proliferation and drug resistance development. We have previously shown that natural and synthetic ester bond-containing tea polyphenols are selective inhibitors of the chymotrypsin-like activity of the proteasome. The most abundant catechin in green tea is (-)-epigallocatechin-3-gallate [(-)-EGCG], which has been found by many laboratories to exhibit the most potent anticancer activity. We have reported that (-)-EGCG is also the most effective proteasome inhibitor among all the natural green tea catechins tested. Unfortunately, (-)-EGCG is very unstable in neutral and alkaline conditions. In an attempt to increase the stability and thus the efficacy, we synthesized several (-)-EGCG analogs with acetyl protected -OH groups as prodrugs. Here we report, for the first time, that these acetylated synthetic tea analogs are much more potent than natural (-)-EGCG in inhibiting the proteasome in cultured tumor cells. Consistently, these protected analogs showed much higher potency than (-)-EGCG to inhibit proliferation and transforming activity and to induce apoptosis in human leukemic, prostate, breast, and simian virus 40-transformed cells. Additionally, these protected analogs had greatly reduced effects on human normal and non-transformed cells. Therefore, these peracetate protected tea polyphenols are more efficacious than (-)-EGCG and possess great potential to be developed into novel anticancer drugs. Identification of the cytosolic metabolite(s) of peracetate-protected polyphenols in cultured tumor cells and examination of their in vivo tumor growth-inhibitory activity are currently underway in our laboratory.
有人提出蛋白酶体活性对于肿瘤细胞增殖和耐药性发展至关重要。我们之前已经表明,天然和含合成酯键的茶多酚是蛋白酶体胰凝乳蛋白酶样活性的选择性抑制剂。绿茶中最丰富的儿茶素是(-)-表没食子儿茶素-3-没食子酸酯[(-)-EGCG],许多实验室已发现它具有最强大的抗癌活性。我们报道过,(-)-EGCG也是所有测试的天然绿茶儿茶素中最有效的蛋白酶体抑制剂。不幸的是,(-)-EGCG在中性和碱性条件下非常不稳定。为了提高其稳定性从而提高疗效,我们合成了几种带有乙酰基保护-OH基团的(-)-EGCG类似物作为前药。在此我们首次报道,这些乙酰化的合成茶类似物在抑制培养的肿瘤细胞中的蛋白酶体方面比天然的(-)-EGCG更有效。一致地,这些受保护的类似物在抑制人白血病、前列腺、乳腺和猿猴病毒40转化细胞的增殖和转化活性以及诱导凋亡方面比(-)-EGCG表现出更高的效力。此外,这些受保护的类似物对人正常和未转化细胞的影响大大降低。因此,这些全乙酰化保护的茶多酚比(-)-EGCG更有效,并且具有开发成新型抗癌药物的巨大潜力。我们实验室目前正在鉴定培养的肿瘤细胞中全乙酰化保护的多酚的胞质代谢物,并检测它们的体内肿瘤生长抑制活性。